Clinical Trial Update: Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the addition of panitumumab to chemoradiotherapy for squamous cell carcinoma of the head and neck has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Status: COMPLETED